Presentation is loading. Please wait.

Presentation is loading. Please wait.

Meropenem in cystic fibrosis patients infected with resistant Pseudomonas aeruginosa or Burkholderia cepacia and with hypersensitivity to β-lactam antibiotics 

Published byAustin Bates Modified over 5 years ago

Similar presentations

Presentation on theme: "Meropenem in cystic fibrosis patients infected with resistant Pseudomonas aeruginosa or Burkholderia cepacia and with hypersensitivity to β-lactam antibiotics "— Presentation transcript:

1 Meropenem in cystic fibrosis patients infected with resistant Pseudomonas aeruginosa or Burkholderia cepacia and with hypersensitivity to β-lactam antibiotics  Oana Ciofu, Tim Jensen, Tacjana Pressler, Helle Krogh Johansen, Christian Koch, Niels H⊘iby  Clinical Microbiology and Infection  Volume 2, Issue 2, Pages (October 1996) DOI: /j tb00212.x Copyright © 1996 European Society of Clinical Infectious Diseases Terms and Conditions

2 Figure 1 Minimal inhibitory concentrations (MICs) of meropenem against P. aeruginosa isolated from 10 CF patients before and after a 2-week intravenous treatment with meropenem. The box and whisker plots represent the median, 25, 75 and 90 centiles of the values. Clinical Microbiology and Infection 1996 2, 91-98DOI: ( /j tb00212.x) Copyright © 1996 European Society of Clinical Infectious Diseases Terms and Conditions

Download ppt "Meropenem in cystic fibrosis patients infected with resistant Pseudomonas aeruginosa or Burkholderia cepacia and with hypersensitivity to β-lactam antibiotics "

Similar presentations

The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa.

The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Secretory IgA as a diagnostic tool for Pseudomonas aeruginosa respiratory colonization  Kasper Aanaes, Helle Krogh Johansen, Steen Seier Poulsen, Tacjana.

Secretory IgA as a diagnostic tool for Pseudomonas aeruginosa respiratory colonization  Kasper Aanaes, Helle Krogh Johansen, Steen Seier Poulsen, Tacjana.
Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times  F.B. Spencker, L. Staber, T. Lietz,

Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times  F.B. Spencker, L. Staber, T. Lietz,
Intravenous antibiotics given for 2 weeks do not eradicate persistent Staphylococcus aureus clones in cystic fibrosis patients  C. Andersen, B.C. Kahl,

Intravenous antibiotics given for 2 weeks do not eradicate persistent Staphylococcus aureus clones in cystic fibrosis patients  C. Andersen, B.C. Kahl,
Benchmarking inappropriate empirical antibiotic treatment

Benchmarking inappropriate empirical antibiotic treatment
Frequency and molecular diversity of Pseudomonas aeruginosa upon admission and during hospitalization: a prospective epidemiologic study  Dominique S.

Frequency and molecular diversity of Pseudomonas aeruginosa upon admission and during hospitalization: a prospective epidemiologic study  Dominique S.
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients  R. Cantón, N. Cobos,

Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients  R. Cantón, N. Cobos,
Approach to diagnosis of infective endocarditis

Approach to diagnosis of infective endocarditis
Interaction of insulin and Burkholderia cepacia

Interaction of insulin and Burkholderia cepacia
Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients  Helle Krogh Johansen, Samuel.

Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients  Helle Krogh Johansen, Samuel.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Pseudomonas aeruginosa diversity in distinct paediatric patient groups

Pseudomonas aeruginosa diversity in distinct paediatric patient groups
Secretory IgA as a diagnostic tool for Pseudomonas aeruginosa respiratory colonization  Kasper Aanaes, Helle Krogh Johansen, Steen Seier Poulsen, Tacjana.

Secretory IgA as a diagnostic tool for Pseudomonas aeruginosa respiratory colonization  Kasper Aanaes, Helle Krogh Johansen, Steen Seier Poulsen, Tacjana.
Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995  Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,

Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995  Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,
Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98  J. Robert, E. Cambau, K. Grenet, D.

Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98  J. Robert, E. Cambau, K. Grenet, D.
Hydatid disease Clinical Microbiology and Infection

Hydatid disease Clinical Microbiology and Infection
Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection—A.

Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection—A.
Louis Pasteur, from crystals of life to vaccination

Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.

Similar presentations

Ads by Google